Obesity, Insulin Level Impact Prostate Cancer Survival (HealthDay)
Obesity, Insulin Level Impact Prostate Cancer Survival (HealthDay)
HealthDay - SUNDAY, Oct. 5 (HealthDay News) — Men who are overweight and who have high insulin levels when they are diagnosed with prostate cancer may be more likely to die from the disease, research shows.
Mesothelioma and Litigation Posted By : pnisbet
Mesothelioma is a disease with a poor prognosis, and it is important that patients and their relatives understand how to get cash for asbestos lung cancer palliative care. The right attorney is a must if this is to be funded by the proceedings of a mesothelioma compensation claim. More: continued here Source: http://mesothelioma-cancerhome.info/mesothelioma/mesothelioma-and-litigation-posted-by-pnisbet
Mesothelioma is a disease with a poor prognosis, and it is important that patients and their relatives understand how to get cash for asbestos lung cancer palliative care. The right attorney is a must if this is to be funded by the proceedings of a mesothelioma compensation claim.
More: continued here
Source: http://mesothelioma-cancerhome.info/mesothelioma/mesothelioma-and-litigation-posted-by-pnisbet
How to Handle Cancer Pain: Self Hypnosis Pain Relief for Cancer
Self-hypnosis is a useful tool to handle cancer pain in combination with other forms of treatment.
Cancer is a Preventable Disease of our Western Life-style
Cancer rates have been rising steadily since the 1940s. But this is mostly true in Western life-style societies. By understanding how this happened, we can all learn to protect ourselves better.
Mesothelioma Treatment Moves to Phase III Trial
Merck & Co., Inc announced today its investigational trial of vorinostat (ZOLINZA®), the Company’s oral histone deacetylase (HDAC) inhibitor, in patients with advanced malignant pleural mesothelioma has progressed into Phase III investigation and is currently enrolling patients who previously failed or are intolerant to prior therapies such as chemotherapy. The decision to move forward follows [...]
Merck & Co., Inc announced today its investigational trial of vorinostat (ZOLINZA®), the Company’s oral histone deacetylase (HDAC) inhibitor, in patients with advanced malignant pleural mesothelioma has progressed into Phase III investigation and is currently enrolling patients who previously failed or are intolerant to prior therapies such as chemotherapy. The decision to move forward follows [...]
Source: http://blog.mesorc.com/2008/06/06/mesothelioma-treatment-moves-to-phase-iii-trial/
Tags: decades, Mesothelioma Cancer, chest wall, chest, illinois mesothelioma lawyer, Mesothelioma Asbestos, hospital dr, asbestos fibers, risk, tea can fight
